Stroke Prevention and Treatment for Youth with Sickle Cell Anemia: Current Practice and Challenges and Promises for the Future
Current Neurology and Neuroscience Reports · 2024-11 · 24 (11) · 537-546
DOI: 10.1007/s11910-024-01372-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Neurology and Neuroscience Reports, online erschienen am 21.09.2024. Verfasst von Susan Creary und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology/Oncology/BMT, Dept of Pediatrics, The Ohio State University and Nationwide Children's Hospital, 700 Children's Drive, Columbus…. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Stroke. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Schlaganfall
Abstract (Originalsprache)
Purpose of Review Sickle cell anemia (SCA) is an autosomal recessive inherited hemoglobinopathy that results in a high risk of stroke. SCA primarily affects an underserved minority population of children who are frequently not receiving effective, multi-disciplinary, preventative care. This article reviews primary and secondary stroke prevention and treatment for children with SCA for the general adult and pediatric neurologist, who may play an important role in providing critical neurologic evaluation and care to these children. Recent Findings Primary stroke prevention is efficacious at reducing ischemic stroke risk, but it is not consistently implemented into clinical practice in the United States, resulting in these children remaining at high risk. Acute symptomatic stroke management requires neurology involvement and emergent transfusion to limit ischemia. Furthermore, while chronic transfusion therapy is a proven secondary preventative modality for those with prior symptomatic or silent cerebral infarcts, it carries significant burden. Newer therapies (e.g., stem cell therapies and voxelotor) deserve further study as they may hold promise in reducing stroke risk and treatment burden. Summary Effective primary and secondary stroke prevention and treatment remain a challenge. Informing and engaging neurology providers to recognize and provide critical neurologic evaluation and treatment has potential to close care gaps.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology/Oncology/BMT, Dept of Pediatrics, The Ohio State University and Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH, 43205, USA.
- Division of Neurology, Dept of Pediatrics, The Ohio State University and Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH, 43205, USA.
- Division of Critical Care, Dept of Pediatrics, The Ohio State University and Nationwide Children's Hospital, Columbus, OH, 43205, USA.
- Division of Neurology, Dept of Pediatrics, The Ohio State University and Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH, 43205, USA. Warren.Lo@nationwidechildrens.org.
Zitieren
APA
Creary, S., Chung, M. G., Villella, A. D., & Lo, W. D. (2024). Stroke Prevention and Treatment for Youth with Sickle Cell Anemia: Current Practice and Challenges and Promises for the Future. Current Neurology and Neuroscience Reports, 24(11), 537-546. https://doi.org/10.1007/s11910-024-01372-9
Vancouver
Creary S, Chung MG, Villella AD, Lo WD. Stroke Prevention and Treatment for Youth with Sickle Cell Anemia: Current Practice and Challenges and Promises for the Future. Current Neurology and Neuroscience Reports. 2024;24(11):537-546. doi:10.1007/s11910-024-01372-9
BibTeX
@article{Creary2024,
author = {Creary, Susan and Chung, Melissa G and Villella, Anthony D and Lo, Warren D},
title = {Stroke Prevention and Treatment for Youth with Sickle Cell Anemia: Current Practice and Challenges and Promises for the Future},
journal = {Current Neurology and Neuroscience Reports},
year = {2024},
volume = {24},
number = {11},
pages = {537--546},
doi = {10.1007/s11910-024-01372-9}
}
EUVIMED